Get started
Author

Junyue Tao

Observed name: Tao, Junyue
ORCID: 0000-0003-2095-5958
Observed ORCID: 0000-0003-2095-5958
OpenAlex ID: A5019277401
From microscopes to molecules: The evolution of prostate cancer diagnostics
2024 · Junyue Tao, Xiaokang Bian, et al. · CytoJournal · 11
Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients
2022 · Junyue Tao, Xiao Li, et al. · Frontiers in Oncology · 10
Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
2022 · Cheng Yang, Lei Chen, et al. · Cancer Cell International · 8
PDF
Prognostic and immunological implications of cathepsin Z overexpression in prostate cancer
2025 · Junyue Tao, Yiding Chen, et al. · Frontiers in Immunology · 7
Innovative hydrogel-based therapies for ischemia-reperfusion injury： bridging the gap between pathophysiology and treatment
2024 · Weibo Wang, Supeng Tai, et al. · Materials Today Bio · 7
Positive response of a recurrent clear cell sarcoma to anlotinib combined with chemotherapy: A case report
2022 · Junyue Tao, Hao Yang, et al. · Medicine · 5
Autocatalytic Signal Amplification via Orthogonal Recognition of Dual Proteins on the Surface of Serum Extracellular Vesicles for Precise Diagnosis of Prostate Cancer
2025 · Junyue Tao, Lexing Yang, et al. · ACS Sensors · 4
Outcomes of Robot-Assisted Laparoscopic Isthmus Division Using Endoscopic Transection Equipment in the Treatment of Symptomatic Horseshoe Kidney
2021 · Junyue Tao, Gang Liu, et al. · Journal of Laparoendoscopic & Advanced Surgical Techniques · 4
Protective role of exosomes in renal ischemia-reperfusion injury: a systematic review and meta-analysis
2025 · Weibo Wang, Supeng Tai, et al. · Frontiers in Pharmacology · 3
PDF
Cryptococcal invasion: a comprehensive case of adrenal and systemic infection amid immunosuppression
2024 · Supeng Tai, Chaozhao Liang, et al. · BMC Infectious Diseases · 3
PDF
Overexpression of DDX49 in prostate cancer is associated with poor prognosis
2023 · Junyue Tao, Qintao Ge, et al. · BMC Urology · 3
PDF
Comprehensive genomic insights into the genetic causality and comorbidity in urological cancers
2025 · Xiangyu Zhang, Feixiang Yang, et al. · npj Precision Oncology · 2
Association between platelet-to-lymphocyte ratio and high risk for prostate cancer among middle-aged and older US men
2026 · Yifan Chang, Weibo Wang, et al. · Scientific Reports · 1
PDF
Cigarette smoking, smoking cessation, and overactive bladder (OAB): a cross-sectional research of NHANES 2011 to 2018
2025 · Weibo Wang, Supeng Tai, et al. · BMC Public Health · 1
Diagnosis and therapeutic strategies for primary bladder mucinous adenocarcinoma: a case report and literature review
2025 · Xi Cheng, Weibo Wang, et al. · Frontiers in Oncology · 1
PDF
Exploring the association between caffeine intake and benign prostatic hyperplasia: results from the NHANES 2005–2008
2025 · Fei Zhang, Andong Zhang, et al. · Frontiers in Nutrition · 1
PDF
EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort
2022 · Qintao Ge, Jiawei Li, et al. · Frontiers in Pharmacology · 1
Bone metastasis in newly diagnosed prostate cancer: development and external validation of a diagnostic prediction model based on inflammatory-immune indices and clinicopathological factors to support imaging decisions
2026 · Weibo Wang, Chengyang Tian, et al. · BMC Cancer
Single-cell transcriptomic profile unveils distinct immune ecosystems in alcohol- and nonalcohol-associated hepatocellular carcinoma
2026 · Huan Huang, Haotian Chen, et al. · Frontiers in Immunology
PDF
Can social media videos meet patients’ information needs for benign prostatic hyperplasia? A repeated cross-sectional study
2026 · Chengyang Tian, Weibo Wang, et al. · BMC Urology
Positive response of a recurrent clear cell sarcoma to neoadjuvant targeted therapy combined with chemotherapy: a case report
2022 · Junyue Tao, Chang Liu, et al. · Research Square
PDF
Additional file 5 of Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
2022 · Yang, Cheng, Chen, Lei, et al. · Figshare
Additional file 2 of Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
2022 · Yang, Cheng, Chen, Lei, et al. · Figshare
Additional file 6 of Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
2022 · Yang, Cheng, Chen, Lei, et al. · Figshare
Additional file 3 of Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
2022 · Yang, Cheng, Chen, Lei, et al. · Figshare
Works count: 39
Citation count: 72
H-index: 5
I10-index: 2
Year
Topic
Type